Interferon alpha-2b controlled release - Biolex/OctoPlus
Alternative Names: BLX 883 controlled release - Biolex/OctoPlus; LocteronLatest Information Update: 02 Oct 2021
At a glance
- Originator Biolex
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Suspended Hepatitis C